• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内科患者的休克流行病学及预后

Shock epidemiology and outcomes among internal medicine patients.

作者信息

Maluangnon C, Joyjumroon B, Phawanawichian C, Tongyoo S

机构信息

Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

出版信息

South Afr J Crit Care. 2025 May 19;41(1):e2453. doi: 10.7196/SAJCC.2025.v41i1.2453. eCollection 2025.

DOI:10.7196/SAJCC.2025.v41i1.2453
PMID:40927445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12416926/
Abstract

BACKGROUND

Shock, characterised by circulatory hypoperfusion and cellular hypoxia, represents a critical medical condition requiring immediate attention. Despite its significance, there are limited data on shock incidence and outcomes, particularly within the context of Thailand.

OBJECTIVES

This retrospective observational study aimed to investigate the incidence, management and outcomes of shock patients admitted to the internal medicine department of Siriraj Hospital, a referral university hospital in Bangkok, Thailand. Additionally, the study sought to identify factors associated with mortality among these patients.

METHODS

Medical records of patients admitted were reviewed. Shock cases were identified based on specific diagnostic criteria, and demographic and clinical data were extracted for analysis.

RESULTS

A total of 125 patients were included in the study, with septic shock being the most prevalent condition (40.0%), followed by cardiogenic shock (39.2%), hypovolaemic shock (18.4%) and obstructive shock (2.4%). The overall intensive care unit (ICU) admission rate was 46.7%, varying among shock types, with cardiogenic shock patients exhibiting the highest rate. The overall 28-day mortality rate was 23.7%, with septic shock patients admitted to the ICU demonstrating the highest mortality rate (50.0%). The multivariate analysis identified factors associated with mortality, including colloid resuscitation (adjusted odds ratio (aOR) 3.10 (1.08 - 8.9), p=0.036); vasopressor dose of more than 0.2 µg/kg/min (aOR 4.38 (1.39 - 13.74), p=0.011); and renal replacement therapy (aOR 3.43 (1.04 - 11.28), p=0.043).

CONCLUSION

This study provides significant insights into shock incidence, management and outcomes in a tertiary referral hospital in Thailand. It also highlights challenges related to ICU bed availability and identifies predictors of mortality. Early recognition and tailored interventions are crucial for improving outcomes in shock patients.

CONTRIBUTION OF THE STUDY

This study provides the comprehensive evaluation of shock incidence, management and outcomes among internal medicine patients. By identifying critical care resource limitations and key predictors of mortality, the findings offer valuable insights for improving early recognition and tailored interventions in resource-constrained settings.

摘要

背景

休克以循环灌注不足和细胞缺氧为特征,是一种需要立即关注的危急病症。尽管其意义重大,但关于休克发病率和结局的数据有限,尤其是在泰国的背景下。

目的

这项回顾性观察性研究旨在调查泰国曼谷一所转诊大学医院——诗里拉吉医院内科收治的休克患者的发病率、治疗情况和结局。此外,该研究还试图确定这些患者中与死亡率相关的因素。

方法

对收治患者的病历进行回顾。根据特定诊断标准确定休克病例,并提取人口统计学和临床数据进行分析。

结果

该研究共纳入125例患者,其中感染性休克最为常见(40.0%),其次是心源性休克(39.2%)、低血容量性休克(18.4%)和梗阻性休克(2.4%)。重症监护病房(ICU)的总体收治率为46.7%,因休克类型而异,心源性休克患者的收治率最高。总体28天死亡率为23.7%,入住ICU的感染性休克患者死亡率最高(50.0%)。多因素分析确定了与死亡率相关的因素, 包括胶体复苏(校正比值比(aOR)3.10(1.08 - 8.9),p = 0.036);血管活性药物剂量超过0.2 μg/kg/min(aOR 4.38(1.39 - 13.74),p = 0.011);以及肾脏替代治疗(aOR 3.43(1.04 - 11.28),p = 0.043)。

结论

本研究为泰国一家三级转诊医院的休克发病率、治疗情况和结局提供了重要见解。它还突出了与ICU床位可用性相关的挑战,并确定了死亡率的预测因素。早期识别和针对性干预对于改善休克患者的结局至关重要。

研究贡献

本研究对内科患者的休克发病率、治疗情况和结局进行了全面评估。通过确定重症监护资源限制和死亡率的关键预测因素,研究结果为在资源有限的环境中改善早期识别和针对性干预提供了有价值的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92a6/12416926/44f34e41db75/SAJCC-41-1-2453-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92a6/12416926/44f34e41db75/SAJCC-41-1-2453-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92a6/12416926/44f34e41db75/SAJCC-41-1-2453-fig1.jpg

相似文献

1
Shock epidemiology and outcomes among internal medicine patients.内科患者的休克流行病学及预后
South Afr J Crit Care. 2025 May 19;41(1):e2453. doi: 10.7196/SAJCC.2025.v41i1.2453. eCollection 2025.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Systemic Inflammatory Response Syndrome全身炎症反应综合征
4
Epidemiology and outcomes of septic shock in Japan: a nationwide retrospective cohort study from a medical claims database by the Japan Sepsis Alliance (JaSA) study group.日本感染性休克的流行病学与转归:日本脓毒症联盟(JaSA)研究组基于医疗理赔数据库的全国性回顾性队列研究
Crit Care. 2025 Jul 16;29(1):309. doi: 10.1186/s13054-025-05556-8.
5
Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients.与标准护理相比,自动监测用于危重症患者脓毒症的早期检测
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD012404. doi: 10.1002/14651858.CD012404.pub2.
6
Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients.在危重症患者中,依托咪酯单次诱导剂量与其他诱导剂用于气管插管的比较。
Cochrane Database Syst Rev. 2015 Jan 8;1(1):CD010225. doi: 10.1002/14651858.CD010225.pub2.
7
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
8
Characteristics and In-Hospital Outcomes of Patients With Septic Shock in the Adult Medical Intensive Care Unit of a Tertiary Hospital in Ethiopia: A Prospective Observational Study.埃塞俄比亚一家三级医院成人医学重症监护病房感染性休克患者的特征及院内结局:一项前瞻性观察研究。
Health Sci Rep. 2025 Jul 15;8(7):e71064. doi: 10.1002/hsr2.71064. eCollection 2025 Jul.
9
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.

本文引用的文献

1
Comparing Outcomes of Critically Ill Patients in Intensive Care Units and General Wards: A Comprehensive Analysis.比较重症监护病房和普通病房中重症患者的治疗结果:一项综合分析。
Int J Gen Med. 2023 Aug 25;16:3779-3787. doi: 10.2147/IJGM.S422791. eCollection 2023.
2
State of Shock: Contemporary Vasopressor and Inotrope Use in Cardiogenic Shock.心源性休克时血管加压素和正性肌力药物的应用现状
J Am Heart Assoc. 2023 Aug;12(15):e029787. doi: 10.1161/JAHA.123.029787. Epub 2023 Jul 25.
3
Epidemiology and Burden of Sepsis at Thailand's Largest University-Based National Tertiary Referral Center during 2019.
2019年泰国最大的国立大学三级转诊中心的脓毒症流行病学及负担情况
Antibiotics (Basel). 2022 Jul 5;11(7):899. doi: 10.3390/antibiotics11070899.
4
Incidence and Outcomes of Nontraumatic Shock in Adults Using Emergency Medical Services in Victoria, Australia.澳大利亚维多利亚州使用紧急医疗服务的成年人非创伤性休克的发生率和结局。
JAMA Netw Open. 2022 Jan 4;5(1):e2145179. doi: 10.1001/jamanetworkopen.2021.45179.
5
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.拯救脓毒症运动:2021年脓毒症和脓毒性休克国际管理指南
Intensive Care Med. 2021 Nov;47(11):1181-1247. doi: 10.1007/s00134-021-06506-y. Epub 2021 Oct 2.
6
Shock in China 2018 (SIC-study): a cross-sectional survey.2018年中国休克(SIC研究):一项横断面调查。
Ann Transl Med. 2021 Aug;9(15):1219. doi: 10.21037/atm-21-310.
7
In-Hospital Death after Septic Shock Reversal: A Retrospective Analysis of In-Hospital Death among Septic Shock Survivors at Thailand's Largest National Tertiary Referral Center.脓毒性休克逆转后院内死亡:泰国最大国家三级转诊中心脓毒性休克幸存者院内死亡的回顾性分析。
Am J Trop Med Hyg. 2021 Jan;104(1):395-402. doi: 10.4269/ajtmh.20-0896.
8
Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis.2009 年至 2019 年期间欧洲、北美和澳大利亚脓毒症和脓毒性休克患者的死亡率:系统评价和荟萃分析的结果。
Crit Care. 2020 May 19;24(1):239. doi: 10.1186/s13054-020-02950-2.
9
Vasopressor therapy in critically ill patients with shock.血管加压素治疗休克危重症患者。
Intensive Care Med. 2019 Nov;45(11):1503-1517. doi: 10.1007/s00134-019-05801-z. Epub 2019 Oct 23.
10
Cardiogenic Shock.心源性休克
J Am Heart Assoc. 2019 Apr 16;8(8):e011991. doi: 10.1161/JAHA.119.011991.